{
    "nct_id": "NCT02312960",
    "official_title": "A Phase 4 Long-term Follow-up Study to Define the Safety Profile of Radium-223 Dichloride",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* Subject was previously enrolled in a selected company sponsored feeder trial, and has received at least 1 dose of radium 223 dichloride or placebo in the feeder trial\n\nExclusion Criteria:\n\n* Not applicable to this follow up study\n\nsex: ALL\n\nminimumAge: 18 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "Subject was previously enrolled in a selected company sponsored feeder trial, and has received at least 1 dose of radium 223 dichloride or placebo in the feeder trial",
        "exclusion": "Not applicable to this follow up study"
    }
}